CS MEDICA A/S’s CANNASEN® Pain Patch receives approval from Israel’s Ministry of Health and is set to debut as the first-ever OTC product with CBD in Israel.
CS MEDICA's CANNASEN® Pain Patch has made history as the first-ever Over-the-Counter (OTC) product with CBD to receive approval from Israel’s Ministry of Health. This milestone achievement now opens the door for the full portfolio of CANNASEN® Medical device products under the Forbe Healthcare Ltd. agreement to enter the Israeli market.Back in June 2022, CS MEDICA (”CS MEDICA” or the ”Company”) signed an agreement with Forbe Healthcare Ltd. covering Israel and Palestine. The agreement comprised the complete range of CANNASEN® Medical device products, with a contract of 852,000 units